AquAgro Fund I

Desalitech, Inc. specializes in designing, developing, and manufacturing advanced industrial reverse osmosis systems for water purification. Founded in 2008 by Professor Avi Efraty, the company initially operated under the name Advanced Desalination Technologies. Its flagship product, the ReFlex system, addresses diverse applications such as pure water supply, boiler feed water, and wastewater reuse, while the ReFlex Max system focuses on high salinity and seawater desalination. Additionally, Desalitech offers ReFlex Smart, a monitoring and control software that enhances system management. The company serves a wide range of industries, including food and beverage, oil and gas, mining, consumer goods, municipal reuse, and power generation, catering to both domestic and international clients. Based in Newton, Massachusetts, Desalitech operates as a subsidiary of DuPont de Nemours, Inc. since January 2020. Its cutting-edge technology autonomously adapts to changing conditions, simplifying reverse osmosis operations and reducing water costs and operational challenges for clients.

EnzymoCore is a start-up company specializing in the development of biocatalyst substitutes for chemical catalysts used in the production of biodiesel fuels. Founded in 2007 and headquartered in Shefa-'Amr, Israel, the company focuses on enzymatic technologies that facilitate biodiesel production from a variety of vegetable and animal-based feedstocks, particularly those high in fatty acids. This innovative approach enables organizations and industries to produce biodiesel more conveniently and affordably, addressing the growing demand for renewable energy sources as partial substitutes for petroleum-based fuels.

Evogene Ltd. is a computational biology company headquartered in Rehovot, Israel, focused on the discovery and development of life-science products across various industries, including agriculture, human health, and industrial applications. Utilizing its Computational Predictive Biology (CPB) platform, Evogene combines deep biological insights with big data and artificial intelligence to enhance product development efficiency and efficacy. The Agriculture segment works on seed traits and ag-chemical products aimed at improving crop performance for species such as corn, soybean, and cotton. In the Human Health sector, the company develops microbiome-based therapeutics targeting immuno-oncology and gastrointestinal disorders, along with medical cannabis products. The Industrial Applications segment concentrates on enhancing castor bean seeds for biofuel production. Evogene operates globally, with a presence in the United States, Israel, and Brazil, and maintains strategic collaborations and licensing agreements with major agricultural firms. Founded in 1999, the company leverages advanced technologies to transform life-science product development processes.